drugset / Trial / NCT03737604

TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant

NCT03737604 ↗

Phase 4 Active not recruiting 200 enrolled University of California, Davis
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is a comparison of the analgesic efficacy of transversus abdominis plane (TAP) blocks with ropivacaine bolus plus continuous ropivacaine infusion via catheters versus single shot TAP blocks with liposomal bupivacaine.

Timeline

Start
2018-10-04
Primary completion
2026-09-12
Completion
2026-09-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 133 mg Other
Comparator Ropivacaine Other / unclassified 0.2 % Other
Comparator Lidocaine Other / unclassified 5 ml Other

Indications

No indication recorded.